Literature DB >> 19942322

[Use of antivirals in influenza pandemics].

Eduard Diogène Fadini, Dolores Rodríguez Cumplido, Montserrat Bosch Ferrer.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19942322      PMCID： PMC7024424          DOI： 10.1016/j.aprim.2009.10.009

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  8 in total

1.  Global transmission of oseltamivir-resistant influenza.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2009-03-02       Impact factor: 91.245

2.  The evolution of influenza resistance and treatment.

Authors:  David M Weinstock; Gianna Zuccotti
Journal:  JAMA       Date:  2009-03-02       Impact factor: 56.272

Review 3.  Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.

Authors:  Toshihiro Tanaka; Ken Nakajima; Atsuko Murashima; Facundo Garcia-Bournissen; Gideon Koren; Shinya Ito
Journal:  CMAJ       Date:  2009-06-15       Impact factor: 8.262

Review 4.  Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.

Authors:  Matthew Shun-Shin; Matthew Thompson; Carl Heneghan; Rafael Perera; Anthony Harnden; David Mant
Journal:  BMJ       Date:  2009-08-10

5.  Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-01       Impact factor: 17.586

6.  Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-22       Impact factor: 17.586

7.  Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-09-11       Impact factor: 17.586

8.  Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Authors:  Nila J Dharan; Larisa V Gubareva; John J Meyer; Margaret Okomo-Adhiambo; Reginald C McClinton; Steven A Marshall; Kirsten St George; Scott Epperson; Lynnette Brammer; Alexander I Klimov; Joseph S Bresee; Alicia M Fry
Journal:  JAMA       Date:  2009-03-02       Impact factor: 56.272
  8 in total
  1 in total

1.  [Antivirals and pandemic flu].

Authors:  José María Eiros Bouza; Alberto Pérez Rubio; Javier Castrodeza Sanz
Journal:  Aten Primaria       Date:  2010-06-16       Impact factor: 1.137
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.